An application made for this job — a tailored resume and cover letter that speak straight to the posting.
NeoGenomics Laboratories in the Portland area is seeking an Oncology Sales Specialist to drive growth across an OR and South ID territory. This overlay role partners with TBMs and RD to win new oncology groups and expand opportunities.
You will engage hematologist/oncologists, hospital networks, and academic centers, promoting molecular products while delivering market feedback and account growth. Travel up to 75% is required to meet goals and support customers.
We believe in career development and empowering our employees. Not only do we provide career coaches internally, but we offer many training opportunities to expand your knowledge base! We have highly competitive benefits with a variety HMO and PPO options. We have company 401k match along with an Employee Stock Purchase Program. We have tuition reimbursement, leadership development, and even start employees off with 16 days of paid time off plus holidays. We offer wellness courses and have highly engaged employee resource groups. Come join the Neo team and be part of our amazing World Class Culture!
As an employer, we promise to provide you with a purpose driven mission in which you have the opportunity to save lives by improving patient care through the exceptional work you perform. Together, we will become the world's leading cancer reference laboratory.
The Oncology Sales Specialist (OSS) is an oncology diagnostic sales rep that serves as an overlay specialist. The OSS is responsible for supporting oncology customers and opportunities within the assigned territory. The OSS is responsible for ensuring coordination of sales efforts with the respective Territory Business Manager(s) (TBMs) and Regional Director (RD). The OSS will proactively identify opportunities and target new oncology groups to sell oncology products and focus on growth of new products. The OSS will work closely with the TBM to understand the oncology customer’s needs, align on solutions, negotiate and close. The OSS will also be responsible for expanding or upselling within current oncology groups.
The OSS will be expected to interact with hematologist/oncologists, medical oncologists, academic oncologists, surgical oncologists and gynecologic oncologists, as necessary, and this interaction will take place, but is not limited to, oncology groups, hospital oncology groups, academic centers, pathology lab, interventional radiology suites and surgery centers.
Ability to travel as required by role (up to 75% of the time). Some overnight travel may be